HEPTRA NOVA® | FDA-Approved Liver Support with Resmetirom, TUDCA & NAD+ (Clinically Proven for NAFLD/NASH)

HEPTRA NOVA is a liver support formula containing Resmetirom, TUDCA, and NAD⁺ aimed at reversing fatty liver, reducing liver scarring, and regenerating hepatocytes.

• The description claims HEPTRA NOVA targets NAFLD, NASH, and early-stage liver cirrhosis.
• The description claims Resmetirom directly reduces liver fat and fibrosis by accelerating hepatic lipid metabolism.
• The description claims Resmetirom improves liver enzymes, reverses steatosis, and reduces cardiovascular risk associated with metabolic liver disease.
• The description claims TUDCA reduces oxidative stress, prevents cell apoptosis, and regenerates liver tissues.
• The description claims Resmetirom is FDA approved for liver cirrhosis, fatty liver, and other liver problems.